F. Y. Aoki

4.6k total citations · 1 hit paper
41 papers, 1.8k citations indexed

About

F. Y. Aoki is a scholar working on Epidemiology, Immunology and Virology. According to data from OpenAlex, F. Y. Aoki has authored 41 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Epidemiology, 8 papers in Immunology and 7 papers in Virology. Recurrent topics in F. Y. Aoki's work include Herpesvirus Infections and Treatments (14 papers), Influenza Virus Research Studies (10 papers) and Poxvirus research and outbreaks (7 papers). F. Y. Aoki is often cited by papers focused on Herpesvirus Infections and Treatments (14 papers), Influenza Virus Research Studies (10 papers) and Poxvirus research and outbreaks (7 papers). F. Y. Aoki collaborates with scholars based in Canada, United States and United Kingdom. F. Y. Aoki's co-authors include Nelson Kinnersley, Penelope Ward, Sylvie Trottier, Agnès Rode, Lawrence R. Stanberry, Karl G. Nicholson, S L Spruance, Adrian Mindel, Anthony L. Cunningham and Lesley Scott and has published in prestigious journals such as The Lancet, Clinical Infectious Diseases and Journal of Allergy and Clinical Immunology.

In The Last Decade

F. Y. Aoki

41 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial

2000 606 citations F. Y. Aoki et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
F. Y. Aoki Canada	20	1.5k	399	195	174	159	41	1.8k
Rick A. Barbarash United States	11	1.2k 0.8×	281 0.7×	80 0.4×	125 0.7×	37 0.2×	15	1.5k
Simon Portsmouth United States	24	1.5k 1.0×	786 2.0×	253 1.3×	322 1.9×	351 2.2×	62	2.9k
Sylvie Trottier Canada	20	1.3k 0.9×	942 2.4×	110 0.6×	223 1.3×	205 1.3×	63	2.0k
Steve Black United States	20	1.4k 0.9×	335 0.8×	114 0.6×	49 0.3×	80 0.5×	27	1.9k
Donald M. Poretz United States	21	648 0.4×	445 1.1×	60 0.3×	90 0.5×	132 0.8×	40	1.6k
Laurie Kamimoto United States	25	1.5k 1.0×	623 1.6×	203 1.0×	104 0.6×	27 0.2×	30	2.2k
H Grant Stiver Canada	23	599 0.4×	300 0.8×	112 0.6×	98 0.6×	63 0.4×	60	1.4k
Robert G. Sharrar United States	16	771 0.5×	269 0.7×	302 1.5×	549 3.2×	150 0.9×	25	2.3k
Weigong Zhou United States	13	674 0.5×	635 1.6×	376 1.9×	129 0.7×	45 0.3×	18	1.7k
Thomas Weinke Germany	19	900 0.6×	416 1.0×	117 0.6×	90 0.5×	63 0.4×	49	1.7k

Countries citing papers authored by F. Y. Aoki

Since Specialization

Citations

This map shows the geographic impact of F. Y. Aoki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Y. Aoki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Y. Aoki more than expected).

Fields of papers citing papers by F. Y. Aoki

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. Y. Aoki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Y. Aoki. The network helps show where F. Y. Aoki may publish in the future.

Co-authorship network of co-authors of F. Y. Aoki

This figure shows the co-authorship network connecting the top 25 collaborators of F. Y. Aoki. A scholar is included among the top collaborators of F. Y. Aoki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. Y. Aoki. F. Y. Aoki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gorfinkel, Iris, F. Y. Aoki, Shelly McNeil, et al.. (2013). Seroprevalence of HSV-1 and HSV-2 antibodies in Canadian women screened for enrolment in a herpes simplex virus vaccine trial. International Journal of STD & AIDS. 24(5). 345–349. 11 indexed citations

Rubinstein, Eitan, Gerald Predy, Laura Sauvé, et al.. (2011). The responses of Aboriginal Canadians to adjuvanted pandemic (H1N1) 2009 influenza vaccine. Canadian Medical Association Journal. 183(13). E1033–E1037. 13 indexed citations

Langley, Joanne M., F. Y. Aoki, Brian J. Ward, et al.. (2011). A nasally administered trivalent inactivated influenza vaccine is well tolerated, stimulates both mucosal and systemic immunity, and potentially protects against influenza illness. Vaccine. 29(10). 1921–1928. 28 indexed citations

Sacks, Stephen L., F. Y. Aoki, Alain Martel, Stephen D. Shafran, & M. Lassonde. (2005). Clinic-Initiated, Twice-Daily Oral Famciclovir for Treatment of Recurrent Genital Herpes: A Randomized, Double-Blind, Controlled Trial. Clinical Infectious Diseases. 41(8). 1097–1104. 19 indexed citations

Aoki, F. Y., Stephen K. Tyring, Francisco Díaz‐Mitoma, et al.. (2005). Single-Day, Patient-Initiated Famciclovir Therapy for Recurrent Genital Herpes: A Randomized, Double-Blind, Placebo-Controlled Trial. Clinical Infectious Diseases. 42(1). 8–13. 82 indexed citations

Bernstein, David I., F. Y. Aoki, S K Tyring, et al.. (2005). Safety and Immunogenicity of Glycoprotein D--Adjuvant Genital Herpes Vaccine. Clinical Infectious Diseases. 40(9). 1271–1281. 62 indexed citations

Menec, Verena, Leonard MacWilliam, & F. Y. Aoki. (2002). Hospitalizations and Deaths Due to Respiratory Illnesses During Influenza Seasons: A Comparison of Community Residents, Senior Housing Residents, and Nursing Home Residents. The Journals of Gerontology Series A. 57(10). M629–M635. 40 indexed citations

Aoki, F. Y.. (2002). Early administration of oral oseltamivir increases the benefits of influenza treatment. Journal of Antimicrobial Chemotherapy. 51(1). 123–129. 322 indexed citations

Caeseele, Paul Van, et al.. (2001). Rapid Pharmacotherapeutic Intervention for an Influenza a Outbreak in the Canadian Arctic: Lessons from the Sanikiluaq Experience. International Journal of Circumpolar Health. 60(4). 640–648. 1 indexed citations

10.

Stanberry, Lawrence R., Anthony L. Cunningham, Adrian Mindel, et al.. (2000). Prospects for Control of Herpes Simplex Virus Disease through Immunization. Clinical Infectious Diseases. 30(3). 549–566. 143 indexed citations

11.

Aoki, F. Y., et al.. (1998). Amantadine acetylation may be effected by acetyltransferases other than NAT1 or NAT2. Canadian Journal of Physiology and Pharmacology. 76(7-8). 701–706. 15 indexed citations

12.

Blondeau, Joseph M., F. Y. Aoki, & J.I. Nagy. (1993). Immunohistological characterisation of acute herpes simplex virus infection of lumbar dorsal root ganglia in the rat. Journal of Medical Microbiology. 38(4). 265–269. 3 indexed citations

13.

Blondeau, Joseph M. & F. Y. Aoki. (1992). In vitro reactivation of latent herpes simplex virus by the demethylating compound hexamethylene-bis-acetamide. Journal of Virological Methods. 40(3). 323–329. 2 indexed citations

14.

Sacks, Stephen L., Walter F. Schlech, M. John Gill, et al.. (1991). Randomized, Double-Blind, Placebo-Controlled, Clinic-Initiated, Canadian Multicenter Trial of Topical Edoxudine 3.0% Cream in the Treatment of Recurrent Genital Herpes. The Journal of Infectious Diseases. 164(4). 665–672. 18 indexed citations

15.

Grymonpre, Ruby, et al.. (1991). Prescribing Patterns for Older Heavy Drug Users Living in the Community. DICP. 25(2). 186–190. 10 indexed citations

16.

Aoki, F. Y., et al.. (1989). Effect of acute experimental influenza a virus pneumonia on concentration of alpha1-acid glycoprotein in mouse serum. Inflammation. 13(6). 659–672. 2 indexed citations

17.

Whitley, Richard J., Charles A. Alford, Martin Hirsch, et al.. (1987). Factors indicative of outcome in a comparative trial of acyclovir and vidarabine for biopsy-proven herpes simplex encephalitis. Infection. 15(S1). S3–S8. 22 indexed citations

18.

Aoki, F. Y., et al.. (1982). Pseudomonas folliculitis in a resort whirlpool.. PubMed Central. 127(4). 277–277. 5 indexed citations

19.

Turner, G. S., Karl G. Nicholson, D. A. J. Tyrrell, & F. Y. Aoki. (1982). Evaluation of a human diploid cell strain rabies vaccine: final report of a three year study of pre-exposure immunization. Journal of Hygiene. 89(1). 101–110. 32 indexed citations

20.

Aoki, F. Y., et al.. (1975). [Study on gamma-glutamyl transpeptidase activity in urine. I. Determination of gamma-glutamyl transpeptidase activity in urine and normal values of urinary gamma-glutamyl transpeptidase (author's transl)].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 23(10). 819–22. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact